Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
The Value of In-House Medical Affairs to the MSL E205 • May 14, 2024 • 29 mins
Summary
Erlene Seymour, Medical Director, US Medical Affairs Hematology at BeiGene discusses the value of In House or HQ Medical Affairs to the MSL.
Learn more about…
👉 Why is it important for MSLs to know about their inhouse counterparts and what comes from their support
👉 What makes in house medical affairs so valuable to MSLs and to the organization
👉 Advice for MSLs in how they should view and interact with their inhouse counterparts
👉 Advice for MSLs that may want to pursue a role in house or HQ medical affairs position
👉 What is it that helps MSLs stand out and separate themselves from the others
MSLs, in-house medical affairs, HQ medical affairs, Medical Science Liaison, career advice
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary